Chromatin immunoprecipitation (ChIP) is used to enrich DNA fragments associated with a specific chromatin-bound protein or histone modification. In cross-linking ChIP, protein–DNA interactions are fixed in cells, chromatin is fragmented, target-associated fragments are immunoprecipitated with an antibody, and the recovered DNA is analysed by qPCR or sequencing.
The protocol below is a general starting workflow for mammalian cultured cells. ChIP is highly target- and sample-dependent: cross-linking, chromatin fragmentation, antibody amount, wash stringency and input cell number must be optimised. For ChIP-seq, follow current quality-control and replicate guidance appropriate to your study.
Protocol at a glance
| Best suited to | Testing protein-DNA occupancy or histone modifications at defined loci (ChIP-qPCR) or genome-wide (ChIP-seq). |
|---|---|
| Typical starting material | Cultured cells or tissue processed under validated cross-linking and chromatin-fragmentation conditions. |
| Critical variables | Antibody specificity, cross-linking, fragment-size distribution, input material, wash stringency and positive/negative loci. |
| Core controls | Input DNA, IgG/background control, positive locus, negative locus and biological replicates. |
| Major warning | ChIP signal is only as trustworthy as the antibody and chromatin preparation. |
Safety
Formaldehyde is hazardous. Perform cross-linking and formaldehyde waste handling in accordance with your institutional risk assessment, local regulations and chemical-safety procedures, typically in a certified fume hood with appropriate PPE.
Equipment and reagents
- Cultured cells or validated tissue preparation
- Formaldehyde and glycine
- Ice-cold PBS
- Protease inhibitor cocktail
- Nuclear/chromatin extraction buffers
- Sonicator or validated enzymatic fragmentation system such as MNase
- ChIP-grade target-specific antibody
- Protein A/G magnetic or agarose beads matched to the antibody isotype/species
- Magnetic rack if using magnetic beads
- Low-, medium- and/or high-stringency wash buffers
- Elution buffer
- RNase A and Proteinase K where used
- DNA purification columns or validated phenol–chloroform workflow
- qPCR reagents or sequencing library-preparation reagents
Cross-linking ChIP procedure
- Harvest healthy cells. Use a consistent cell state and record passage, confluency and treatment conditions. Keep sufficient material for biological replicates.
- Cross-link protein–DNA complexes. A widely used starting condition is 1% formaldehyde for approximately 10 minutes at room temperature. Over-cross-linking can mask epitopes and reduce chromatin shearing efficiency.
- Quench cross-linking. Add glycine to a final concentration of approximately 125 mM and incubate for about 5 minutes with gentle mixing.
- Wash with ice-cold PBS. Collect cells and keep material cold from this point unless a later step specifies otherwise.
- Lyse cells and isolate chromatin. Use a chromatin extraction workflow appropriate to the target and sample type, with fresh protease inhibitors.
- Fragment chromatin. Optimise sonication or enzymatic digestion. As a guide, cross-linking ChIP protocols commonly target approximately 150–300 bp for histone ChIP and roughly 200–700 bp for many non-histone targets, but the optimum depends on the target and downstream analysis.
- Validate fragment size. Remove a small aliquot, reverse cross-links and assess DNA fragment distribution before committing the full sample to immunoprecipitation.
- Reserve input chromatin. Keep a defined fraction of chromatin before IP for later normalisation and quality control.
- Prepare antibody and beads. Use a ChIP-grade antibody and Protein A/G beads compatible with the antibody. Antibody amount should follow validated supplier guidance or a titration; different targets may require different amounts.
- Immunoprecipitate. Incubate chromatin with antibody-bound beads, commonly overnight at 4°C with gentle rotation.
- Wash the beads. Use a validated series of wash buffers with increasing stringency where appropriate to remove non-specific chromatin while retaining target complexes.
- Elute chromatin complexes. Recover the immunoprecipitated material from the beads using a validated elution buffer.
- Reverse cross-links. A common approach is incubation at approximately 65°C for several hours or overnight. Treat with RNase and Proteinase K where required by the workflow.
- Purify DNA. Use a validated DNA purification column or organic extraction method.
- Analyse enrichment. For ChIP-qPCR, compare a known positive locus, negative locus, input and IgG/background control. For ChIP-seq, assess library quality, sequencing depth, enrichment and replicate concordance using an established analysis pipeline.
Controls
- Input DNA: a fraction of total chromatin taken before IP; required for normalisation.
- IgG control: non-specific antibody control to estimate background immunoprecipitation.
- Positive locus: genomic region known to be enriched for the target protein or histone mark.
- Negative locus: region not expected to be occupied by the target.
- Positive antibody control: a robust ChIP antibody such as histone H3 can help distinguish sample-preparation problems from target-antibody problems where appropriate.
- Biological replicates: important for ChIP-seq and for robust biological interpretation.
ChIP-qPCR interpretation
Enrichment can be expressed as percent input or relative enrichment depending on the experimental design. Use validated primer pairs with appropriate amplification efficiency and keep input, positive-control and negative-control loci in the same analysis. High enrichment at a positive locus with low IgG/background signal supports a successful assay.
ChIP-seq quality considerations
- Use well-characterised antibodies or validated epitope-tag strategies.
- Evaluate fragment-size distribution before library preparation.
- Include biological replicates and appropriate input/control DNA.
- Use established enrichment and reproducibility metrics rather than relying on read count alone.
- Document antibody lot, cell state, cross-linking and sonication parameters because these can materially affect reproducibility.
Recommendations and warnings
- Formaldehyde is hazardous. Handle and dispose of it under your institutional chemical-risk assessment, typically in a suitable fume hood with appropriate PPE.
- Over-cross-linking is not safer for the assay. Excess fixation can reduce epitope accessibility and make chromatin harder to fragment.
- Validate fragmentation on every new sample type or sonicator setup. A protocol copied from another cell line can give a completely different DNA-size distribution.
- Use the same antibody lot across a study where possible. ChIP performance can vary substantially between lots even when western blot performance looks similar.
- Do not rely on IgG alone. A positive locus and a biologically negative locus provide more informative controls for enrichment and specificity.
- ChIP-qPCR primer efficiency matters. Poorly performing primer pairs can create apparent enrichment differences unrelated to immunoprecipitation.
ChIP-qPCR quality-control recommendations
Before interpreting biology, confirm that input DNA amplifies reproducibly, the positive-control locus is enriched over the negative locus, IgG/background is low, and technical qPCR replicates are consistent. For histone marks, enrichment may span broad regions; transcription-factor ChIP often produces narrower occupancy patterns and can require more careful fragment-size optimisation.
ChIP-seq quality considerations
For sequencing experiments, biological replication, sequencing depth, library complexity, enrichment metrics and reproducibility between replicates matter more than total read count alone. ENCODE consortium work has shown that antibody validation, replicate design and data-quality metrics materially affect whether a ChIP-seq dataset can support biological conclusions.
Limitations
- Cross-linking can alter epitope accessibility and create indirect protein associations.
- Antibody quality is a major determinant of specificity.
- Excessive sonication can damage epitopes or over-fragment chromatin; insufficient fragmentation reduces resolution and immunoprecipitation efficiency.
- ChIP enrichment does not by itself prove direct functional regulation.
- ChIP-seq requires sufficient sequencing depth and robust computational quality control.
Troubleshooting
| Problem | Possible cause | What to try |
|---|---|---|
| Low enrichment | Poor antibody, weak target occupancy, inappropriate cross-linking or insufficient chromatin | Confirm a positive locus, use a ChIP-grade antibody, optimise cross-linking and increase starting material where justified. |
| High IgG/background signal | Non-specific antibody/bead binding or insufficient washing | Block beads where appropriate, increase wash stringency cautiously and optimise antibody amount. |
| Chromatin fragments too large | Insufficient sonication/digestion | Increase fragmentation in a controlled optimisation series while keeping samples cold. |
| Chromatin fragments too small | Over-sonication or over-digestion | Reduce fragmentation intensity/duration. |
| Poor qPCR separation between positive and negative loci | Primer performance, poor IP specificity or excessive background | Validate primer efficiency, review controls and re-optimise IP/wash conditions. |
| Poor ChIP-seq reproducibility | Variable cell state, antibody lot, fragmentation or library quality | Standardise upstream handling, record reagent lots and use biological replicates with established QC metrics. |
Frequently asked questions
What fragment size should I target for ChIP?
There is no universal value. Many sonication workflows aim for a broad few-hundred-base-pair distribution, but the optimal range depends on target type, sample and downstream analysis. Validate empirically rather than relying on sonicator time alone.
How much antibody should I use?
Use an amount supported by ChIP validation or titration. Excess antibody can increase background, while too little can limit recovery. Antibody mass should be considered relative to chromatin input and bead capacity.
Is IgG a sufficient negative control?
No. IgG is useful for non-specific immunoprecipitation background, but a negative genomic locus and, where possible, a target-depleted biological control add stronger evidence of specificity.
Can a western-blot antibody be assumed to work in ChIP?
No. ChIP requires recognition of the target in cross-linked chromatin and enough affinity to enrich target-associated DNA under stringent wash conditions.
Related ABMIUM protocols
- RNA Immunoprecipitation (RIP) Protocol
- PCR, RT-PCR and qPCR Protocol
- Immunoprecipitation (IP) Protocol
References and primary methods
- Generation of high-quality chromatin immunoprecipitation DNA template for high-throughput sequencing. J Vis Exp. 2013.
- Chromatin immunoprecipitation to assay dynamic histone modification in activated gene expression in human cells. J Vis Exp. 2011.
- Landt SG et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012;22:1813–1831.
- Characterization of epigenetic histone activation/repression marks by ChIP-qPCR. Methods Mol Biol. 2019.
Relevant ABMIUM products
ABM1327 Anti-Human/Mouse/Rat Histone H3 Antibody [B552] is explicitly listed in the ABMIUM catalogue for ChIP and CUT&Tag as well as WB/IHC/IF/ICC/IP/ELISA. It is therefore a relevant example of an application-matched ChIP antibody listing. It should still be validated for your species, locus strategy and chromatin preparation. For another ChIP target, browse primary antibodies or use Find your MATCH and we can compare application evidence before selection.
Explore more with ABMIUM
Planning ChIP around another transcription factor or histone mark? Use Find your MATCH with the target, species and ChIP format, or explore ChIP-related antibodies. For adjacent workflows, see the qPCR protocol.